We engaged with the management team at IVI Middle East well ahead of the sale process which allowed us a in depth understanding of business and the IVF opportunity in the Gulf region. Gaurav Marathe, head Lincoln’s Healthcare Group in India and CEO India, commented, “We are delighted to have advised the shareholders of IVI Middle East on the sale to Gulf Capital. With Gulf Capital’s support, we want to continue deepening our presence in the Gulf region and to grow this into a global platform.” Suresh Soni, CEO of IVI Middle East, commented on the transaction, “In Gulf Capital we have found a highly reputable and financially-strong partner to help us realize the further development of our company. The company’s embryologists working in these laboratories are extensively trained, providing them exposure to global best practices in IVF. IVI Middle East has an exceptional infrastructure backed by ESHRE trained doctors. The research-driven approach to treatment methodology drives the higher success rates. IVI Middle East offers personalized treatment and advanced treatment methodologies in IVF. Since its formation, IVI Middle East has delivered significantly better medical outcomes whilst ensuring the safety of patients coupled with the highest ethical standards. The company is positioned to continue to deliver accelerated growth in a market that is growing at 10%+ every year. IVI Middle East is the largest global player in the Gulf region offering world-class facilities and clinical protocols comparable to the highest global success rates. The company has two full-service clinics in Abu Dhabi and Muscat along with one outpatient clinic in the Dubai. Back to Transactions IVI RMA Global and other shareholders have sold their stake in IVI Middle East to Gulf Capitalįounded in 2015 by IVI (now IVIRMA), Suresh Soni, Dr Human Fatemi, IVI Middle East emerged as the leading IVF provider in the Middle East market.
0 kommentar(er)
